4/A
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-23-069048
Director acquired 34,360 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Albers Jeffrey W. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-24 | Conversion : show line 1 in the form | +34,360 | 34,360 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-22 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +50,000 | 50,000 | D |
| 2023-11-24 | Conversion : show line 3 in the form Series A Preferred Stock | −859 | 0 | I |
Loading xslF345X05/ownership.xml…